Clinical Trials for Exeliom Biosciences

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Exeliom Biosciences

Clinical Trials (2)

NCT06448572
EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.
PHASE1/PHASE2Recruiting
21 participants
Started: Jul 16, 2024 · Completed: Oct 1, 2028
1 condition2 sponsors1 location
NCT06306014
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients
PHASE1/PHASE2Recruiting
56 participants
Started: May 7, 2024 · Completed: Jan 7, 2027
2 conditions2 sponsors9 locations